• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香港老年人对新冠病毒病第二剂加强针接种的犹豫态度:一项随机电话调查

Hesitancy to Receive the Second COVID-19 Vaccine Booster Dose among Older Adults in Hong Kong: A Random Telephone Survey.

作者信息

Chan Paul Shing-Fong, Lee Marco Lok-Tin, Fang Yuan, Yu Fuk-Yuen, Ye Danhua, Chen Siyu, Kawuki Joseph, Liang Xue, Wang Zixin

机构信息

Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.

Department of Health and Physical Education, The Education University of Hong Kong, Hong Kong, China.

出版信息

Vaccines (Basel). 2023 Feb 8;11(2):392. doi: 10.3390/vaccines11020392.

DOI:10.3390/vaccines11020392
PMID:36851269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9963661/
Abstract

A second COVID-19 vaccine booster dose is effective and safe for older adults. This study investigated hesitancy to take up a second COVID-19 vaccine booster dose and its determinants among older adults in Hong Kong. Participants were Chinese-speaking community-dwelling adults aged 65 years or above. Telephone numbers were randomly selected from up-to-date telephone directories. A total of 370 participants completed the telephone survey. Logistic regression models were fitted for data analysis. Among the participants, half (52.4%) were hesitant to receive the second COVID-19 vaccine booster dose. After adjustment for significant background characteristics, perceived benefits (AOR: 0.50, 95%CI: 0.42, 0.60), cues to action (AOR: 0.39, 95%CI: 0.30, 0.52), and perceived self-efficacy (AOR: 0.37, 95%CI: 0.21, 0.66) of receiving the second booster dose were associated with lower vaccine hesitancy. Perceived barriers (AOR: 1.23, 95%CI: 1.12, 1.34) and vaccine fatigue (tired of receiving repeated COVID-19 vaccination) (AOR: 1.90, 95%CI: 1.52, 2.38) were associated with higher vaccine hesitancy. Level of hesitancy to receive the second booster dose was high among older adults in Hong Kong. Health authorities should address vaccine fatigue and modify perceptions related to the second booster dose.

摘要

第二剂新冠病毒疫苗加强针对于老年人是有效且安全的。本研究调查了香港老年人接种第二剂新冠病毒疫苗加强针的犹豫情况及其决定因素。参与者为65岁及以上说中文的社区居住成年人。电话号码是从最新的电话簿中随机抽取的。共有370名参与者完成了电话调查。采用逻辑回归模型进行数据分析。在参与者中,一半(52.4%)对接种第二剂新冠病毒疫苗加强针持犹豫态度。在对显著的背景特征进行调整后,对接受第二剂加强针的感知益处(比值比:0.50,95%置信区间:0.42,0.60)、行动提示(比值比:0.39,95%置信区间:0.30,0.52)以及感知自我效能(比值比:0.37,95%置信区间:0.21,0.66)与较低的疫苗犹豫相关。感知障碍(比值比:1.23,95%置信区间:1.12,1.34)和疫苗疲劳(厌倦重复接种新冠病毒疫苗)(比值比:1.90,95%置信区间:1.52,2.38)与较高的疫苗犹豫相关。香港老年人对接种第二剂加强针的犹豫程度较高。卫生当局应解决疫苗疲劳问题,并改变与第二剂加强针相关的观念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/9963661/2f9238ab61e2/vaccines-11-00392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/9963661/2f9238ab61e2/vaccines-11-00392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd0d/9963661/2f9238ab61e2/vaccines-11-00392-g001.jpg

相似文献

1
Hesitancy to Receive the Second COVID-19 Vaccine Booster Dose among Older Adults in Hong Kong: A Random Telephone Survey.香港老年人对新冠病毒病第二剂加强针接种的犹豫态度:一项随机电话调查
Vaccines (Basel). 2023 Feb 8;11(2):392. doi: 10.3390/vaccines11020392.
2
Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey.香港社区居住老年人接种新冠疫苗加强针的促进因素和障碍:一项基于人群的随机电话调查
Vaccines (Basel). 2022 Jun 17;10(6):966. doi: 10.3390/vaccines10060966.
3
The Changes in Levels and Barriers of Physical Activity Among Community-Dwelling Older Adults During and After the Fifth Wave of COVID-19 Outbreak in Hong Kong: Repeated Random Telephone Surveys.香港第五波新冠疫情期间及之后社区老年人身体活动水平和障碍的变化:重复随机电话调查
JMIR Aging. 2023 Jan 23;6:e42223. doi: 10.2196/42223.
4
The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.中国60岁及以上人群对新冠病毒疫苗加强针的风险认知与犹豫态度之间的关联
Vaccines (Basel). 2022 Jul 12;10(7):1112. doi: 10.3390/vaccines10071112.
5
Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.香港南亚少数族裔对 COVID-19 疫苗接种的多层次决定因素:基于网络的横断面调查。
JMIR Public Health Surveill. 2021 Nov 9;7(11):e31707. doi: 10.2196/31707.
6
COVID-19 Vaccine Booster Hesitancy in Malaysia: A Web-Based Cross-Sectional Study.马来西亚对新冠疫苗加强针的犹豫态度:一项基于网络的横断面研究。
Vaccines (Basel). 2023 Mar 13;11(3):638. doi: 10.3390/vaccines11030638.
7
Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.基于健康信念模型(HBM)的中国老年人对 COVID-19 疫苗加强针的接受情况及其影响因素:一项全国性横断面研究。
Front Public Health. 2022 Dec 15;10:986916. doi: 10.3389/fpubh.2022.986916. eCollection 2022.
8
Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study.用于促进未接种或对接种加强针犹豫不决的年轻成年人接种 COVID-19 疫苗的聊天机器人的疗效、可用性和可接受性:预-后试点研究。
J Med Internet Res. 2022 Oct 4;24(10):e39063. doi: 10.2196/39063.
9
Governmental Incentives, Satisfaction with Health Promotional Materials, and COVID-19 Vaccination Uptake among Community-Dwelling Older Adults in Hong Kong: A Random Telephone Survey.香港社区居住老年人的政府激励措施、对健康宣传材料的满意度以及新冠疫苗接种情况:一项随机电话调查
Vaccines (Basel). 2022 May 6;10(5):732. doi: 10.3390/vaccines10050732.
10
Dynamic Trends and Underlying Factors of COVID-19 Vaccine Booster Hesitancy in Adults: Cross-Sectional Observational Study.成年人对 COVID-19 疫苗加强针犹豫不决的动态趋势和潜在因素:横断面观察性研究。
JMIR Public Health Surveill. 2023 Aug 1;9:e44822. doi: 10.2196/44822.

引用本文的文献

1
Effectiveness of stage-of-change (SOC)-tailored interventions in increasing uptake of any type of vaccination: A systematic review and meta-analysis.改变阶段(SOC)定制干预措施在提高任何类型疫苗接种率方面的有效性:一项系统评价和荟萃分析。
Appl Psychol Health Well Being. 2025 May;17(2):e70022. doi: 10.1111/aphw.70022.
2
The Potential for Twice-Annual Influenza Vaccination to Reduce Disease Burden.每年接种两次流感疫苗以减轻疾病负担的潜力。
Influenza Other Respir Viruses. 2025 Mar;19(3):e70052. doi: 10.1111/irv.70052.
3
Parental Hesitancy toward Seasonal Influenza Vaccination for Children under the Age of 18 Years and Its Determinants in the Post-Pandemic Era: A Cross-Sectional Survey among 1175 Parents in China.

本文引用的文献

1
The Changes in Levels and Barriers of Physical Activity Among Community-Dwelling Older Adults During and After the Fifth Wave of COVID-19 Outbreak in Hong Kong: Repeated Random Telephone Surveys.香港第五波新冠疫情期间及之后社区老年人身体活动水平和障碍的变化:重复随机电话调查
JMIR Aging. 2023 Jan 23;6:e42223. doi: 10.2196/42223.
2
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study.第四剂 COVID-19 BNT162b2 mRNA(第二剂加强针)疫苗的安全性:一项前瞻性和回顾性队列研究。
Lancet Respir Med. 2023 Feb;11(2):139-150. doi: 10.1016/S2213-2600(22)00407-6. Epub 2022 Nov 18.
3
大流行后时代18岁以下儿童季节性流感疫苗接种的家长犹豫态度及其影响因素:中国1175名家长的横断面调查
Vaccines (Basel). 2024 Aug 29;12(9):988. doi: 10.3390/vaccines12090988.
4
COVID-19 Vaccine Booster Hesitancy among the Elderly in Malaysian Residential Care Homes: A Cross-Sectional Study in Klang Valley.马来西亚养老院老年人对新冠疫苗加强针的犹豫态度:巴生谷地区的一项横断面研究
Vaccines (Basel). 2024 Mar 4;12(3):268. doi: 10.3390/vaccines12030268.
5
Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China.癌症老年患者对接受 COVID-19 二价疫苗加强针的意愿:中国四个省份的分层分析。
Front Public Health. 2024 Feb 22;12:1298070. doi: 10.3389/fpubh.2024.1298070. eCollection 2024.
6
The disparity in hesitancy toward COVID-19 vaccination between older individuals in nursing homes and those in the community in Taizhou, China.中国泰州养老院和社区老年人对 COVID-19 疫苗接种犹豫不决的差异。
BMC Geriatr. 2023 Dec 9;23(1):828. doi: 10.1186/s12877-023-04518-5.
7
Assessing the acceptability of COVID-19 vaccine and its booster dose.评估 COVID-19 疫苗及其加强针的可接受性。
Immun Inflamm Dis. 2023 Sep;11(9):e950. doi: 10.1002/iid3.950.
8
Older adults' acceptance of the COVID-19 vaccine: Application of the health belief model.老年人对 COVID-19 疫苗的接受度:健康信念模型的应用。
Nurs Open. 2023 Oct;10(10):6989-7002. doi: 10.1002/nop2.1954. Epub 2023 Jul 23.
9
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.中国新冠病毒灭活疫苗研发综述:聚焦特殊人群的安全性与有效性
Vaccines (Basel). 2023 May 31;11(6):1045. doi: 10.3390/vaccines11061045.
Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: A cross-sectional study.
护士中第二剂 COVID-19 加强针或新 COVID-19 疫苗犹豫的预测因素:一项横断面研究。
J Clin Nurs. 2023 Jul;32(13-14):3943-3953. doi: 10.1111/jocn.16576. Epub 2022 Nov 7.
4
Changes in Parents' COVID-19 Vaccine Hesitancy for Children Aged 3-17 Years before and after the Rollout of the National Childhood COVID-19 Vaccination Program in China: Repeated Cross-Sectional Surveys.中国国家儿童新冠疫苗接种计划推出前后3至17岁儿童家长对新冠疫苗犹豫态度的变化:重复横断面调查
Vaccines (Basel). 2022 Sep 6;10(9):1478. doi: 10.3390/vaccines10091478.
5
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.COVID-19 mRNA 疫苗第二剂加强针在≥50 岁成年人中的安全性监测-美国,2022 年 3 月 29 日至 2022 年 7 月 10 日。
MMWR Morb Mortal Wkly Rep. 2022 Jul 29;71(30):971-976. doi: 10.15585/mmwr.mm7130a4.
6
The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China.中国60岁及以上人群对新冠病毒疫苗加强针的风险认知与犹豫态度之间的关联
Vaccines (Basel). 2022 Jul 12;10(7):1112. doi: 10.3390/vaccines10071112.
7
Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece.普通公众接受第二剂新冠病毒加强针或新型新冠疫苗意愿的预测因素:希腊的一项横断面研究
Vaccines (Basel). 2022 Jun 30;10(7):1061. doi: 10.3390/vaccines10071061.
8
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022.2、3 和 4 剂 COVID-19 mRNA 疫苗在 SARS-CoV-2 奥密克戎 BA.1 和 BA.2/BA.2.12.1 亚谱系占主导地位期间对免疫功能正常成年人的有效性 - VISION 网络,10 个州,2021 年 12 月至 2022 年 6 月。
MMWR Morb Mortal Wkly Rep. 2022 Jul 22;71(29):931-939. doi: 10.15585/mmwr.mm7129e1.
9
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study.加拿大安大略省长期护理居民中第四剂 covid-19 mRNA 疫苗对奥密克戎变异株的有效性:阴性测试设计研究。
BMJ. 2022 Jul 6;378:e071502. doi: 10.1136/bmj-2022-071502.
10
Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey.香港社区居住老年人接种新冠疫苗加强针的促进因素和障碍:一项基于人群的随机电话调查
Vaccines (Basel). 2022 Jun 17;10(6):966. doi: 10.3390/vaccines10060966.